Literature DB >> 20610330

Central Asia: hotspot in the worldwide HIV epidemic.

Claire Thorne1, Nina Ferencic, Ruslan Malyuta, Jadranka Mimica, Tomasz Niemiec.   

Abstract

The HIV epidemic in central Asia (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan) has accelerated since 2000. This expansion in the epidemic is largely attributable to escalating injection drug use, reflecting central Asia's geographic position along major drug trafficking routes. Although up to 75% of cumulative HIV cases have been among injection drug users (IDUs) so far, HIV infections are increasing in other population groups, including female sex workers and their clients, prisoners, and migrants. Among IDUs, risky injecting practices are highly prevalent, and the intersecting epidemic of sexually transmitted infections, particularly syphilis, highlights the potential for sexual transmission of HIV to bridging populations. Few HIV cases in children have been reported so far, with most resulting from nosocomial outbreaks in hospital settings. Some recent progress has been made towards scaling-up prevention, treatment, and care services, including harm reduction for IDUs, although key challenges remain. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20610330     DOI: 10.1016/S1473-3099(10)70118-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  35 in total

1.  The HIV epidemic in Eastern Europe and Central Asia.

Authors:  Jack DeHovitz; Anneli Uuskula; Nabila El-Bassel
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

2.  HIV and people who use drugs in central Asia: confronting the perfect storm.

Authors:  Nabila El-Bassel; Steffanie A Strathdee; Wafaa M El Sadr
Journal:  Drug Alcohol Depend       Date:  2013-08-15       Impact factor: 4.492

3.  Social Support and HIV Risks Among Migrant and Non-Migrant Market Workers in Almaty, Kazakhstan.

Authors:  Gaukhar Mergenova; Stacey A Shaw; Assel Terlikbayeva; Louisa Gilbert; Lenore Gensburg; Sholpan Primbetova; Nabila El-Bassel
Journal:  J Immigr Minor Health       Date:  2017-08

4.  Gender differences between predictors of HIV status among PWID in Ukraine.

Authors:  K F Corsi; S Dvoryak; C Garver-Apgar; J M Davis; J T Brewster; O Lisovska; R E Booth
Journal:  Drug Alcohol Depend       Date:  2014-02-20       Impact factor: 4.492

5.  Multi-level risk factors associated with sex trading among women living with HIV in Kazakhstan: A neglected key population.

Authors:  Alissa Davis; Tina Jiwatram-Negrón; Sholpan Primbetova; Assel Terlikbayeva; Yelena Bilokon; Lyubov Chubukova; Nabila El-Bassel
Journal:  Int J STD AIDS       Date:  2017-05-11       Impact factor: 1.359

6.  HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: implications for HIV prevention, research, and policy.

Authors:  Nabila El-Bassel; Louisa Gilbert; Assel Terlikbayeva; Chris Beyrer; Elwin Wu; Stacey A Shaw; Xin Ma; Mingway Chang; Tim Hunt; Leyla Ismayilova; Sholpan Primbetova; Yelena Rozental; Baurzhan Zhussupov
Journal:  Int J Drug Policy       Date:  2013-11-23

7.  HIV among injection drug users and their intimate partners in Almaty, Kazakhstan.

Authors:  Nabila El-Bassel; Louisa Gilbert; Assel Terlikbayeva; Elwin Wu; Chris Beyrer; Stacey Shaw; Tim Hunt; Xin Ma; Mingway Chang; Leyla Ismayilova; Marat Tukeyev; Baurzhan Zhussupov; Yelena Rozental
Journal:  AIDS Behav       Date:  2013-09

8.  Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.

Authors:  Lyuba Azbel; Maxim Polonsky; Martin Wegman; Natalya Shumskaya; Ainura Kurmanalieva; Akylbek Asanov; Jeffrey A Wickersham; Sergii Dvoriak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2016-06-11

9.  A Phase 1 Randomized, Blinded Comparison of the Pharmacokinetics and Colonic Distribution of Three Candidate Rectal Microbicide Formulations of Tenofovir 1% Gel with Simulated Unprotected Sex (CHARM-02).

Authors:  Hiwot Hiruy; Edward J Fuchs; Mark A Marzinke; Rahul P Bakshi; Jennifer C Breakey; Wutyi S Aung; Madhuri Manohar; Chen Yue; Brian S Caffo; Yong Du; Kaleab Z Abebe; Hans M L Spiegel; Lisa C Rohan; Ian McGowan; Craig W Hendrix
Journal:  AIDS Res Hum Retroviruses       Date:  2015-08-24       Impact factor: 2.205

10.  Short communication: molecular epidemiology of HIV type 1 infection in Kazakhstan: CRF02_AG prevalence is increasing in the southeastern provinces.

Authors:  Ilya Lapovok; Elena Kazennova; Vita Laga; Alexander Vasilyev; Aliya Utegenova; Asylkhan Abishev; Natalya Dzissyuk; Marat Tukeev; Marina Bobkova
Journal:  AIDS Res Hum Retroviruses       Date:  2014-06-19       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.